2023
|
G/S
|
Medicinal and pharmaceutical preparations used for the
treatment of multidrug-resistant tubercul... |
|
G/S
|
Antiretroviral medication for the treatment of hiv/aids. |
|
Invention
|
Crystalline polymorphs of mitapivat and mitapivat hemisulfate. The present disclosure relates to ... |
|
G/S
|
Pharmaceutical preparations for the treatment of HIV. |
|
Invention
|
Polymorphic form of larotrectinib sulfate. The present invention provides a crystalline Form M1 o... |
|
Invention
|
Polymorphic forms of bictegravir sodium. The present disclosure relates to novel crystalline form... |
|
G/S
|
Medicinal and pharmaceutical preparations for the treatment
of diabetes. |
|
Invention
|
An improved process for the preparation of edoxaban intermediate. The present invention relates t... |
|
Invention
|
Polymorphic forms of ozanimod hydrochloride. The present invention provides crystalline polymorph... |
|
G/S
|
Medicinal and pharmaceutical preparation for the treatment
of bacterial infections. |
2022
|
G/S
|
Medicinal and pharmaceutical preparations for the treatment
of tuberculosis. |
|
Invention
|
Cocrystal of roxadustat and nicotinamide. The present invention provides Cocrystal of Roxadustat ... |
|
Invention
|
Process for the preparation of pure salcaprozate sodium. The present invention relates to process... |
|
Invention
|
Polymorphic forms of sacubitril-telmisartan (1:1). The present invention provides polymorphic for... |
|
Invention
|
A process for the preparation of larotrectinib or its salts. The present invention provides a pro... |
2021
|
Invention
|
Pharmaceutical composition comprising meloxicam.
The present invention relates to novel pharmace... |
|
Invention
|
Pharmaceutical composition comprising meloxicam. The present invention relates to novel pharmaceu... |
|
Invention
|
Treatments for sars-cov-2 infection (covid-19). Active agent combinations are provided for the tr... |
|
Invention
|
An improved process for the preparation of upadacitinib intermediate. The present invention provi... |
|
Invention
|
Combination antibacterial composition and method for antibacterial therapy. Fixed-dose pharmaceut... |
|
Invention
|
Improved process for the preparation of roxadustat. A synthetic route for the preparation of Roxa... |
|
Invention
|
A process for the preparation of upadacitinib and its intermediates. The present invention provid... |
|
Invention
|
Polymorphic forms of glecaprevir. The present disclosure relates to novel crystalline and amorpho... |
2020
|
G/S
|
Medicinal and pharmaceutical preparations. |
|
Invention
|
Novel polymorph of ribociclib succinate. The present invention relates to novel crystalline form ... |
|
G/S
|
Pharmaceutical and medicinal preparations for the treatment
of hiv/aids. |
|
Invention
|
Methods and intermediates for preparing hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-y... |
|
Invention
|
Novel polymorphs of ribociclib succinate. The present invention relates to novel crystalline form... |
|
Invention
|
An improved process for the preparation of valbenazine and its salts. The present invention relat... |
|
G/S
|
Pharmaceutical or medicinal preparation for use as
antiretroviral. |
|
Invention
|
The process for the preparation of upadacitinib and its intermediates. The present invention prov... |
|
Invention
|
Process for the preparation of abaloparatide.
A process for the preparation of Abaloparatide or ... |
|
Invention
|
Process for the preparation of abaloparatide. The present invention relates to an improved proces... |
|
Invention
|
Cocrystal of roxadustat and d-proline. "Co-crystal of Roxadustat" The present invention relates t... |
|
Invention
|
Process for the preparation of bedaquiline fumarate. The present disclosure relates to an improve... |
|
G/S
|
Pharmaceutical preparations for the treatment of fungal
infections. |
|
Invention
|
Polymorphic forms 5-[3-[(1s)-2,3-dihydro-1-[(2-hydroxyethyl) amino]-1h-inden-4-yl]-1,2,4-oxadiazo... |
2019
|
Invention
|
Processes for the preparation of amorphous tenofovir alafenamide hemifumarate and a premix thereo... |
|
Invention
|
Amorphous (rac)-tramadol.hcl-celecoxib (1:1). The present invention provides an amorphous form of... |
|
Invention
|
Meloxicam co-crystals.
Co-crystals of meloxicam co-formers can be prepared by co-crystallization... |
|
Invention
|
Meloxicam co-crystals. Co-crystals of meloxicam co-formers can be prepared by co-crystallization ... |
|
Invention
|
Polymorphic forms of vadadustat. Described is a process for the preparation of crystalline Form C... |
|
Invention
|
Polymorphic forms of avatrombopag maleate. The present invention relates generally to pharmaceuti... |
|
Invention
|
Tramadol hbr-celecoxib co-crystal.
The present invention provides a novel 1:1 co-crystal of (rac... |
|
Invention
|
Tramadol hbr-celecoxib co-crystal. The present invention provides a novel 1:1 co-crystal of (rac)... |
|
Invention
|
Process for preparation of pure plecanatide.
The present disclosure provides methods for purifie... |
|
Invention
|
Process for preparation of pure plecanatide. The present disclosure provides methods for purified... |
|
Invention
|
Polymorphic forms of bictegravir and its sodium salt. The present disclosure provides crystalline... |
|
Invention
|
Novel crystalline forms of rucaparib (s)-camsylate salt and rucaparib free base. The present inve... |
|
Invention
|
Process for the preparation of abametapir and its pharmaceutically acceptable salts.
The present... |
|
Invention
|
Process for the preparation of abametapir and its pharmaceutically acceptable salts. The present ... |
|
Invention
|
Process for the preparation of sotagliflozin. Sotagliflozin may be prepared using schemes and int... |
|
Invention
|
Deutetrabenazine polymorphs and methods for their preparation. Crystalline Form M1 of deutetraben... |
2018
|
Invention
|
Polymorphic forms of venetoclax. The present invention relates to crystalline forms of venetoclax... |
|
G/S
|
Pharmaceutical preparations for the treatment of Hepatitis C(HCV) |
|
G/S
|
Pharmaceutical preparations for the treatment of adult patients with chronic Hepatitis C Virus (H... |
|
Invention
|
Novel polymorphs of (5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide hydroc... |
2017
|
Invention
|
Polymorphic forms of venclexta. The present disclosure relates to crystalline forms of venetoclax... |